- Home
- OLB vs INM Comparison
OLB vs INM Comparison
Compare OLB & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLB | INM |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 8.8M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OLB | INM |
|---|---|---|
| Price | $0.19 | $14.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.6M | 64.4K |
| Earning Date | 11-17-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.48 | 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,676,907.00 | $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.16 | $0.58 |
| 52 Week High | $1.80 | $2.33 |
Technical Indicators
Market Signals| Indicator | OLB | INM |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 99.23 |
| Support Level | N/A | $1.00 |
| Resistance Level | $0.40 | N/A |
| Average True Range (ATR) | 0.03 | 0.50 |
| MACD | -0.02 | 1.24 |
| Stochastic Oscillator | 6.31 | 84.72 |
Price Performance
Historical ComparisonAbout OLB The OLB Group Inc.
The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.